Last reviewed · How we verify

NCT01169064

Topical Silver for Prevention of Wound Infection Post Cesarean Delivery: A Randomized Controlled Trial

Terminated NA Results posted Last updated 19 April 2017
What this trial tests

NA trial testing Silver-containing surgical dressing in Wound Infection in 475 participants. Terminated before completion.

Timeline
1 July 2010
Primary endpoint
1 July 2012
1 July 2012

Quick facts

Lead sponsorVanderbilt University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment475
Start date1 July 2010
Primary completion1 July 2012
Estimated completion1 July 2012
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University

Who can join

Adults 18 to 50, female only, with Wound Infection. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan to investigate the rate of infection in women experiencing cesarean sections at Vanderbilt University Medical Center (VUMC) by comparing the infection rate based on a randomized choice of silver-containing wound dressings to soft cloth adhesive wound dressings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Wound Infection

Currently open trials in the same condition.

Other Vanderbilt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01169064.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing